A Recurrent Ischemic Stroke Stabilization after Using Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)
Journal of the Korean Neurological Association
; : 41-44, 2016.
Article
in Ko
| WPRIM
| ID: wpr-20857
Responsible library:
WPRO
ABSTRACT
Current stroke guidelines recommend the administration of non-vitamin-K-antagonist oral anticoagulant (NOAC) for the prevention of cardioembolic stroke induced by nonvalvular atrial fibrillation. We report a patient who suffered from recurrent posterior circulation strokes-occurring eight times in 4 months-even under adequate antiplatelet medication. Changing the medication from antiplatelet agents to NOAC stopped the stroke recurrence. We suggest that NOAC has a role in the prevention of recurrent stroke of undetermined etiology in the posterior circulation.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Recurrence
/
Atrial Fibrillation
/
Platelet Aggregation Inhibitors
/
Stroke
Limits:
Humans
Language:
Ko
Journal:
Journal of the Korean Neurological Association
Year:
2016
Type:
Article